Pyridostigmine and low-dose naltrexone for ME/CFS: study protocol for the Life Improvement Trial (LIFT), a randomized, double-blind, placebo-controlled clinical trial
- DOI
- 10.1186/s13063-026-09943-6
- Published
- 2026-08-12
- Container
- Trials
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1186/s13063-026-09943-6,
title = {Pyridostigmine and low-dose naltrexone for ME/CFS: study protocol for the Life Improvement Trial (LIFT), a randomized, double-blind, placebo-controlled clinical trial},
author = {Danielle Meadows and Johanna Squires and Joshua Dibble and Shreya Palwayi and Donna Felsenstein and Linda Tannenbaum and Peng Li and Wenzhong Xiao and Jonas Bergquist and David Systrom},
year = {2026},
journal = {Trials},
doi = {10.1186/s13063-026-09943-6},
url = {https://doi.org/10.1186/s13063-026-09943-6}
}RIS
TY - JOUR TI - Pyridostigmine and low-dose naltrexone for ME/CFS: study protocol for the Life Improvement Trial (LIFT), a randomized, double-blind, placebo-controlled clinical trial AU - Danielle Meadows AU - Johanna Squires AU - Joshua Dibble AU - Shreya Palwayi AU - Donna Felsenstein AU - Linda Tannenbaum AU - Peng Li AU - Wenzhong Xiao AU - Jonas Bergquist AU - David Systrom PY - 2026 JO - Trials DO - 10.1186/s13063-026-09943-6 UR - https://doi.org/10.1186/s13063-026-09943-6 ER -
APA
Meadows, D., Squires, J., Dibble, J., Palwayi, S., Felsenstein, D., Tannenbaum, L., Li, P., Xiao, W., Bergquist, J., & Systrom, D. (2026). Pyridostigmine and low-dose naltrexone for ME/CFS: study protocol for the Life Improvement Trial (LIFT), a randomized, double-blind, placebo-controlled clinical trial. Trials. https://doi.org/10.1186/s13063-026-09943-6
Source records
- crossref · retrieved 2026-11-10T14:11:09.309Z